Smith & Nephew (LON:SN) Stock Crosses Above 200 Day Moving Average - Here's What Happened

Smith & Nephew plc (LON:SN - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,061.66 ($14.27) and traded as high as GBX 1,134 ($15.24). Smith & Nephew shares last traded at GBX 1,128.50 ($15.17), with a volume of 956,974 shares traded.

Smith & Nephew Trading Up 0.2%

The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84. The business has a 50-day simple moving average of GBX 1,099.94 and a two-hundred day simple moving average of GBX 1,065.21. The stock has a market cap of £12.86 billion, a price-to-earnings ratio of 42.25, a P/E/G ratio of 0.46 and a beta of 0.62.

Insider Activity at Smith & Nephew

In related news, insider Jeremy (Jez) Maiden acquired 1,855 shares of Smith & Nephew stock in a transaction on Thursday, May 1st. The stock was purchased at an average cost of GBX 1,070 ($14.38) per share, with a total value of £19,848.50 ($26,674.51). Corporate insiders own 0.19% of the company's stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.